Literature DB >> 12477647

Superficial bladder tumors.

Dominique K Chopin1, Bernard Gattegno.   

Abstract

This article is a summary of the 2001 French Urological Association (AFU) report on superficial bladder cancer. Major topics include histopathological classification, risk categories, natural history of the disease, standard treatments, the impact of molecular biology on clinical practice, the place of cystectomy, and modalities of intravesical instillations.

Entities:  

Mesh：

Year:  2002        PMID： 12477647     DOI： 10.1016/s0302-2838(02)00466-9

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  10 in total

1.  [Not Available].

Authors:  Jihad El Anzaoui; Najib Abakka; Younes El Harrech; Omar Ghoundale; Driss Touiti; Mohammed Lahkim; Jawad Fassi Fihri; Walid Bakzaza; Abdelhadi Mejdane
Journal:  Can Urol Assoc J       Date:  2013-07       Impact factor: 1.862

2.  Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.

Authors:  Chenggang Yang; Yongchun Zhou; Lijuan Zhang; Congguo Jin; Mei Li; Lijuan Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer.

Authors:  C Mian; M Lodde; E Comploj; L Lusuardi; S Palermo; M Mian; K Maier; A Pycha
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

4.  Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms.

Authors:  E Compérat; P Camparo; R Haus; E Chartier-Kastler; B Radenen; F Richard; F Capron; V Paradis
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

Review 5.  5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.

Authors:  Yoshinori Harada; Yasutoshi Murayama; Tetsuro Takamatsu; Eigo Otsuji; Hideo Tanaka
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

6.  XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.

Authors:  Ruchika Gangwar; Anil Mandhani; Rama Devi Mittal
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-19       Impact factor: 4.553

7.  [Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder].

Authors:  H Isbarn; L Budäus; U Pichlmeier; S Conrad; H Huland; M G Friedrich
Journal:  Urologe A       Date:  2008-05       Impact factor: 0.639

Review 8.  Oncological risk of laparoscopic surgery in urothelial carcinomas.

Authors:  Morgan Rouprêt; Gordon Smyth; Jacques Irani; Laurent Guy; Jean-Louis Davin; Fabien Saint; Christian Pfister; Hervé Wallerand; François Rozet
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

9.  Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma.

Authors:  Meei-Maan Wu; Ching-Fei Li; Li-Fang Lin; Alexander Sheng-Shin Wang; Yeong-Shiau Pu; Hsiu-Hua Wang; Ai-Chung Mar; Chien-Jen Chen; Te-Chang Lee
Journal:  Oncotarget       Date:  2017-04-04

10.  Cell-Level Spatio-Temporal Model for a Bacillus Calmette-Guérin-Based Immunotherapy Treatment Protocol of Superficial Bladder Cancer.

Authors:  Teddy Lazebnik
Journal:  Cells       Date:  2022-08-02       Impact factor: 7.666
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.